ReviewFrontiers in medicine2022

Differences in the Development of Adverse Infusion Reactions to Rituximab in Patients With Systemic Lupus Erythematosus, Rheumatoid Arthritis and Non-Hodgkin's Lymphoma-Enigma Variations.

Sergio Gilaberte Reyzabal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.